Literature DB >> 24450667

Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI.

David V Schacht1, Ken Yamaguchi, Jessica Lai, Kirti Kulkarni, Charlene A Sennett, Hiroyuki Abe.   

Abstract

OBJECTIVE: The purposes of this study were to assess the importance of a personal history of breast cancer as a risk factor for patients referred for screening breast MRI and to evaluate the importance of this risk factor compared with family history.
MATERIALS AND METHODS: A retrospective review of screening breast MRI performed from 2004 to 2012 included a total of 702 patients, 465 of whom had undergone annual MRI and 237 of whom had undergone MRI every 6 months as part of a research protocol.
RESULTS: Of the patients screened, 208 had a personal history of breast cancer, and 345 had a family history as the sole risk factor. An additional 97 patients had both risk factors. The absolute risk for detection of breast cancer at screening MRI among patients with a personal history of cancer was 2.8% (95% CI, 0.6-5.2%). The absolute risk for patients with a strong family history of cancer was 2.0% (95% CI, 0.5-3.5%). The relative risk for detection of breast cancer given a personal history was 1.42 (95% CI, 0.48-4.17) compared with family history. The relative risk when both risk factors were present compared with having only a family history was 3.04 (95% CI, 1.05-8.86).
CONCLUSION: A personal history of breast cancer is an important risk factor for the development of subsequent breast cancer. Given the results, consideration should be given to MRI screening of patients with a personal history of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24450667     DOI: 10.2214/AJR.13.11553

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

1.  Five-year risk of interval-invasive second breast cancer.

Authors:  Janie M Lee; Diana S M Buist; Nehmat Houssami; Emily C Dowling; Elkan F Halpern; G Scott Gazelle; Constance D Lehman; Louise M Henderson; Rebecca A Hubbard
Journal:  J Natl Cancer Inst       Date:  2015-04-22       Impact factor: 13.506

Review 2.  Imaging Surveillance After Primary Breast Cancer Treatment.

Authors:  Diana L Lam; Nehmat Houssami; Janie M Lee
Journal:  AJR Am J Roentgenol       Date:  2017-01-11       Impact factor: 3.959

3.  Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks.

Authors:  Roberta M Strigel; Jennifer Rollenhagen; Elizabeth S Burnside; Mai Elezaby; Amy M Fowler; Frederick Kelcz; Lonie Salkowski; Wendy B DeMartini
Journal:  Acad Radiol       Date:  2016-12-13       Impact factor: 3.173

4.  Performance Benchmarks for Screening Breast MR Imaging in Community Practice.

Authors:  Janie M Lee; Laura Ichikawa; Elizabeth Valencia; Diana L Miglioretti; Karen Wernli; Diana S M Buist; Karla Kerlikowske; Louise M Henderson; Brian L Sprague; Tracy Onega; Garth H Rauscher; Constance D Lehman
Journal:  Radiology       Date:  2017-06-05       Impact factor: 11.105

Review 5.  Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis.

Authors:  Cameron B Haas; Larissa Nekhlyudov; Janie M Lee; Sara H Javid; Mary Bush; Dianne Johnson; Timothy Gleason; Cary Kaufman; Jennifer Specht; Sean Stitham; Karen J Wernli
Journal:  Breast Cancer Res Treat       Date:  2020-04-17       Impact factor: 4.872

6.  Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.

Authors:  Roberta M Strigel; Elizabeth S Burnside; Mai Elezaby; Amy M Fowler; Frederick Kelcz; Lonie R Salkowski; Wendy B DeMartini
Journal:  AJR Am J Roentgenol       Date:  2017-06       Impact factor: 3.959

Review 7.  Breast density implications and supplemental screening.

Authors:  Athina Vourtsis; Wendie A Berg
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

8.  Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.

Authors:  Nariya Cho; Wonshik Han; Boo-Kyung Han; Min Sun Bae; Eun Sook Ko; Seok Jin Nam; Eun Young Chae; Jong Won Lee; Sung Hun Kim; Bong Joo Kang; Byung Joo Song; Eun-Kyung Kim; Hee Jung Moon; Seung Il Kim; Sun Mi Kim; Eunyoung Kang; Yunhee Choi; Hak Hee Kim; Woo Kyung Moon
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

9.  Development and Implementation of an Algorithm to Guide MRI Screening in Patients With a Personal History of Treated Breast Cancer.

Authors:  Roberta M Strigel; Erin Bravo; Amye J Tevaarwerk; Bethany M Anderson; Amy L Stella; Heather B Neuman
Journal:  Clin Breast Cancer       Date:  2020-10-17       Impact factor: 3.225

10.  MRI surveillance for women with a personal history of breast cancer: comparison between abbreviated and full diagnostic protocol.

Authors:  Ko Woon Park; Sol Bee Han; Boo-Kyung Han; Eun Sook Ko; Ji Soo Choi; Sun Jung Rhee; Eun Young Ko
Journal:  Br J Radiol       Date:  2020-01-16       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.